German Biotech Stock News

Volkswagen (XTRA:VOW3) has appointed Andreas Mindt as the new Group Head of Design. Mindt succeeds Michael Mauer as part of a generational transition in the company’s top design leadership. The move signals a refreshed approach to design at group level across the Volkswagen brands. For an automaker of Volkswagen’s scale, design is not just about looks; it shapes brand identity, pricing power, and how models stand out in crowded segments. As XTRA:VOW3 continues to compete across combustion,...

Fresenius Medical Care (XTRA:FME) closed out FY 2025 with Q4 revenue of €5.1b and basic EPS of €1.14, as full year trailing twelve month figures showed total revenue of €19.6b and EPS of €3.36. Over the past year, the company has seen quarterly revenue move between about €4.8b and €5.1b, while basic EPS has ranged from €0.52 in Q1 2025 to €1.14 in Q4 2025. This has occurred alongside trailing twelve month net income of €978m, which sits against earlier figures such as €538m at the end of...

SUSS MicroTec SE recently concluded a new syndicated loan agreement worth €115 million with a five-year term and two optional one-year extensions, replacing its prior €56 million facility that was set to expire in October 2026. By more than doubling its syndicated loan capacity with a consortium of renowned European banks, the company has increased its financial flexibility for general corporate needs and refinancing. Next, we’ll examine how this expanded €115 million syndicated loan...

Stock context and recent performance snapshot Dr. Ing. h.c. F. Porsche (XTRA:P911) has stayed on investors’ radar after recent trading, with the share price closing at €41.55 and short term returns mixed across the past week and month. Over the past 3 months the stock shows a negative total return, and the 1 year and 3 year total return figures are also negative. This may prompt you to look more closely at how current pricing compares with the company’s earnings and balance sheet. See our...

If you are wondering whether Siemens Healthineers is attractively priced at its current level, this article walks through what the numbers suggest and how that might matter for your portfolio. The stock last closed at €41.55, with returns of 1.5% over 7 days, a 4.0% decline over 30 days, a 5.9% decline year to date and a 21.9% decline over 1 year. These moves may catch the eye of investors weighing potential upside against recent share price pressure. Recent news flow around Siemens...

Infineon’s new bond issues and why they matter for equity investors Infineon Technologies (XTRA:IFX) has just raised fresh debt across three new euro bonds, a move that gives the semiconductor group extra flexibility around funding, refinancing, and future investment plans. The company completed fixed income offerings totaling about €2.0b on 12 February 2026, issuing unsubordinated unsecured notes with fixed coupons and staggered maturities in 2031, 2034, and 2037. See our latest analysis for...

Commerzbank stock overview after recent performance data Commerzbank (XTRA:CBK) is back in focus as investors assess its recent share performance, including a roughly flat move over the past month and a positive total return over the past 3 months. See our latest analysis for Commerzbank. While the share price has eased slightly in the last day, a 5.1% 7 day share price return and 5.7% 90 day share price return contrast with a year to date share price decline, alongside a very large 5 year...

Symrise (XTRA:SY1) has launched a €400 million share repurchase program. The company aims to buy back up to 10% of its share capital by October 2026, with redeemed shares reducing registered capital. See our latest analysis for Symrise. At a share price of €75.8, Symrise has seen positive short term momentum with a 30 day share price return of 4.44% and a 90 day return of 7.76%. However, the 1 year total shareholder return of 22.03% decline shows longer term holders have faced weaker outcomes...

Actinium-225 expansion reshapes Eckert & Ziegler’s role in radiopharmaceutical supply Eckert & Ziegler (XTRA:EUZ) has moved its Actinium-225 collaboration with the Czech Academy of Sciences into large scale production, making it one of the few suppliers able to deliver clinically relevant quantities globally. See our latest analysis for Eckert & Ziegler. The Actinium-225 expansion comes as Eckert & Ziegler’s €15.19 share price has a 1 day share price return of 2.5% and a 7 day share price...

TeamViewer (XTRA:TMV) is back in focus after its fourth quarter and full year 2025 earnings, with higher sales but lower full year net profit, alongside refreshed analyst coverage and ratings. See our latest analysis for TeamViewer. The mixed earnings picture and renewed analyst coverage come against a weak share price backdrop, with a 30 day share price return showing a 16.56% decline and a 1 year total shareholder return of 61.75% decline, suggesting sentiment has cooled even as revenue has...

Why the GSPC LNG deal matters for Uniper shares Uniper (XTRA:UN0) has signed a long term LNG supply agreement with Gujarat State Petroleum Corporation in India, linking the German utility more closely to one of the world’s fastest growing energy markets. See our latest analysis for Uniper. Despite the new LNG agreement with GSPC and a recent run of positive short term share price returns, including a 16.5% 90 day share price return to €35.7, Uniper’s 1 year total shareholder return of around...

If you are wondering whether Mercedes-Benz Group is still offering fair value at its current share price, this article will walk through what the numbers suggest and what that could mean for you as a shareholder or prospective investor. The stock last closed at €59.40, with returns of 2.5% over the past week, 3.2% over the past month, a 4.1% decline year to date, and a 5.5% return over the past year, along with a 1.6% return over three years and 50.0% over five years. Recent coverage of...

Investors appear disappointed with thyssenkrupp AG's ( ETR:TKA ) recent earnings, despite the decent statutory profit...

The subdued stock price reaction suggests that Douglas AG's ( ETR:DOU ) strong earnings didn't offer any surprises...

Verbio SE has reported past second-quarter 2025 results showing sales of €456.52 million and net income of €3.38 million, alongside higher first-half sales of €896.22 million and a sharply reduced net loss of €0.663 million compared with the prior year. Alongside these financials, Verbio delivered record production volumes in Europe, with higher ethanol and biomethane output underpinned by improved uptime at key U.S. plants and the ramp-up of new facilities. We’ll now examine how Verbio’s...

Why RENK Group Is Back in Focus RENK Group (XTRA:R3NK) has come back onto investors’ radar after the company reported a record order backlog and higher order intake, supported by increased European defence spending and shifting consensus expectations. See our latest analysis for RENK Group. RENK Group’s recent record order backlog and higher order intake appear to be feeding into sentiment, with a 1-day share price return of 4.83% and year to date share price return of 9.85%. The 1-year total...

If you are wondering whether Siemens at €235.75 is still a sensible entry or hold, the key question is how its current price lines up with its underlying value. The stock has had a mixed run recently, with a 7 day return of an 8.7% decline and a 30 day return of a 9.4% decline, while the 1 year return sits at 6.4% and the 5 year return at 106.9%. These moves sit against a backdrop of ongoing coverage of Siemens as a major European capital goods name. Investors regularly weigh its large...

Why DF Deutsche Forfait (XTRA:DFTK) just jumped onto traders’ radar DF Deutsche Forfait (XTRA:DFTK) drew attention after a sharp intraday price surge on 16 February 2026, accompanied by heavy trading volume ahead of its scheduled earnings announcement on 28 April 2026. See our latest analysis for DF Deutsche Forfait. That sudden jump in trading interest sits on top of a very strong run, with the share price at €8.15 and multi month share price returns many times higher than earlier levels,...

KWS SAAT SE KGaA (XTRA:KWS) reported second quarter sales of €183.1 million and a net loss of €54 million, with a wider half year loss despite broadly stable sales, sharpening focus on earnings quality. See our latest analysis for KWS SAAT SE KGaA. The earnings update lands after a choppy spell for the shares, with a 7 day share price return of a 10.96% decline and a 30 day share price return of a 10.59% decline, even though the 1 year total shareholder return is 20.59%. This suggests longer...

The most recent earnings report from TeamViewer SE ( ETR:TMV ) was disappointing for shareholders. While the headline...

Siltronic’s 2026 guidance and what it means for investors Siltronic (XTRA:WAF) has issued earnings guidance for 2026, indicating that sales are expected to be in the mid single digit percentage range below the prior year, with a significant EBIT decline linked to currency, demand, pricing, and SD closure effects. See our latest analysis for Siltronic. The new 2026 guidance lands after a mixed share price run, with a recent 7 day share price return of negative 6.91% and a 90 day share price...

N4XT Experiences announced a multi-season partnership with SAP to bring AI-enabled retail and enterprise technology to New York Fashion Week, including the recently opened Retail Innovation Lab showcasing immersive shopping tools like smart mirrors and digital product passports. This fashion and retail collaboration adds a high-profile, consumer-facing showcase to SAP’s broader AI push across defense, supply chains, and enterprise consulting partnerships. We’ll now examine how this...

Infineon Technologies AG ( ETR:IFX ) stock is about to trade ex-dividend in 2 days. Typically, the ex-dividend date is...

As European markets navigate volatility, with the STOXX Europe 600 Index reaching new highs yet remaining relatively unchanged, investors are keenly observing potential opportunities amid AI disruption concerns. For those interested in smaller or newer companies, penny stocks—despite their outdated moniker—continue to present intriguing prospects for growth at lower price points. By focusing on stocks with strong financials and solid fundamentals, investors can uncover hidden gems that may...